Jae Yeon Hwang Selected Research

Jae Yeon Hwang Research Topics

Disease

5	Neoplasms (Cancer) 01/2024 - 08/2016
4	Psychotic Disorders (Schizoaffective Disorder) 03/2022 - 01/2010
4	Schizophrenia (Dementia Praecox) 11/2016 - 04/2012
2	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2019
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 05/2017 - 09/2011
1	Non-alcoholic Fatty Liver Disease 10/2023
1	Liver Diseases (Liver Disease) 10/2023
1	Hypersensitivity (Allergy) 03/2022
1	Asthma (Bronchial Asthma) 03/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Extravasation of Diagnostic and Therapeutic Materials 01/2022
1	Fistula 01/2022
1	Hemorrhage 01/2022
1	Cognitive Dysfunction 01/2022
1	Carcinogenesis 12/2021
1	Dementia (Dementias) 03/2021
1	Tibial Plateau Fractures 03/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2016
1	Alzheimer Disease (Alzheimer's Disease) 03/2016
1	Inflammation (Inflammations) 03/2016
1	Gliosis 03/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Nephritis 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2015
1	Edema (Dropsy) 05/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2014
1	Tobacco Use Disorder (Nicotine Dependence) 04/2014
1	Cerebral Cortical Thinning 09/2012

Drug/Important Bio-Agent (IBA)

3	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 02/2012
2	Circular RNAIBA 01/2024 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2016
2	LipopolysaccharidesIBA 03/2016 - 01/2016
2	Indicators and Reagents (Reagents)IBA 09/2012 - 04/2012
1	MicroRNAs (MicroRNA)IBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2024
1	Polychlorinated Biphenyls (PCBs)IBA 10/2023
1	Protein Isoforms (Isoforms)IBA 10/2023
1	6-methyladenineIBA 10/2023
1	RNA Splicing FactorsIBA 10/2023
1	GadoliniumIBA 03/2022
1	IodidesIBA 03/2022
1	isoamylamineIBA 01/2022
1	LipidsIBA 12/2021
1	Trastuzumab (Herceptin)FDA Link 12/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2021
1	Memantine (Namenda)FDA Link 03/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	LuciferasesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Glucose (Dextrose)FDA LinkGeneric 08/2016
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 08/2016
1	Sirolimus (Rapamycin)FDA Link 08/2016
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2016
1	Caspase 3 (Caspase-3)IBA 08/2016
1	Chemokine ReceptorsIBA 03/2016
1	Amyloid beta-PeptidesIBA 03/2016
1	CC ChemokinesIBA 01/2016
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2015
1	Interleukin-8 (Interleukin 8)IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Cetuximab (Erbitux)FDA Link 01/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Ether (Diethyl Ether)IBA 05/2014
1	tricinIBA 05/2014
1	Carbon MonoxideIBA 04/2014
1	Olanzapine (Zyprexa)FDA Link 11/2012
1	sertindole (Serdolect)IBA 11/2012
1	Temazepam (Nocturne)FDA LinkGeneric 09/2012
1	Prednisolone (Predate)FDA LinkGeneric 04/2012
1	Escitalopram FDA Link 09/2011
1	Clozapine (Clozaril)FDA LinkGeneric 01/2010
1	Cocaine (Cocaine HCl)IBA 01/2010

Therapy/Procedure

2	Aftercare (After-Treatment) 03/2019 - 04/2014
2	Drug Therapy (Chemotherapy) 05/2017 - 02/2012
1	Stents 01/2022
1	Radiotherapy 01/2022
1	Chemoradiotherapy 01/2022
1	Therapeutics 03/2021
1	Renal Dialysis (Hemodialysis) 03/2018
1	Meditation 03/2018
1	Vocational Rehabilitation 11/2016
1	Intraperitoneal Injections 01/2016